Jaguar Health (NASDAQ:JAGX) Stock Price Passes Below Two Hundred Day Moving Average – What’s Next?

Jaguar Health, Inc. (NASDAQ:JAGX)’s share price crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $1.42 and traded as low as $0.85. Jaguar Health shares last traded at $0.85, with a volume of 358,850 shares.

Jaguar Health Stock Down 1.7 %

The stock’s fifty day moving average is $1.00 and its 200-day moving average is $1.39. The company has a debt-to-equity ratio of 1.65, a quick ratio of 1.36 and a current ratio of 1.84.

Institutional Trading of Jaguar Health

A hedge fund recently bought a new stake in Jaguar Health stock. Virtu Financial LLC acquired a new position in shares of Jaguar Health, Inc. (NASDAQ:JAGX) in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm acquired 25,591 shares of the biotechnology company’s stock, valued at approximately $35,000. Virtu Financial LLC owned approximately 0.22% of Jaguar Health as of its most recent filing with the Securities & Exchange Commission. Institutional investors own 12.04% of the company’s stock.

About Jaguar Health

Jaguar Health, Inc, a commercial stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress, specifically chronic and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It focuses on developing and commercializing prescription and non-prescription products for companion and production animals; and human products.